Get the Stockscreener App
2.90
0.51%
-0.02
After Hours:
2.90
Xeris Biopharma Holdings Inc Stock (XERS) Forecast
The Xeris Biopharma Holdings Inc (XERS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.3483, representing a -53.51% decrease from the current price of $2.90. The highest analyst price target is $1.3945, and the lowest is $1.3022.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XERS Price Target
Average 4.2113
(+45.22% Upside)
Is Xeris Biopharma Holdings Inc (XERS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.33 | Neutral |
| STOCH(9,6) | 15.83 | Buy |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.0104 | Sell |
| ADX(14) | 23.05 | Neutral |
| William %R | -89.02 | Buy |
| CCI(14) | -205.20 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.189
Sell
|
3.11
Sell
|
| MA20 |
3.191
Sell
|
3.1295
Sell
|
| MA50 |
3.0164
Sell
|
3.0083
Sell
|
| MA100 |
2.7461
Buy
|
2.8095
Buy
|
| MA200 |
2.4967
Buy
|
2.5838
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, XERS could be considered a Strong Sell, with 17 technical analysis indicators signaling 6 Buy signals, 9 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on XERS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.33 indicates that XERS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 15.83 indicates that XERS is oversold. This indicates that XERS price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that XERS is oversold. This suggests that XERS price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.05 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -205.2 indicates that XERS is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term XERS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Xeris Biopharma Holdings Inc financial reports and earnings history, Xeris Biopharma Holdings Inc (XERS) stock could reach $11.11 by 2030, $8.5424 by 2040 and $25.42 by 2050. See the projected annual prices until 2050 of the Xeris Biopharma Holdings Inc stock below:
- Xeris Biopharma Holdings Inc (XERS) is expected to reach an average price of $2.8206 in 2035, with a high prediction of $3.1098 and a low estimate of $3.0306. This indicates an $-2.74% rise from the last recorded price of $2.90.
- Xeris Biopharma Holdings Inc (XERS) stock is projected to chart a bullish course in 2040, with an average price target of $8.0427, representing an $177.34% surge from its current level. The forecast ranges from a conservative $8.2027 to a sky-high $8.5424.
- Our analysts predict Xeris Biopharma Holdings Inc (XERS) to jump 464.08% by 2045, soaring from $16.38 to an average price of $16.36, potentially reaching $16.38. While $16.38 is the low estimate, the potential upside is significant.
- Xeris Biopharma Holdings Inc (XERS) stock is expected to climb by 2050, reaching an average of $24.68, a $751.01% jump from its current level. However, a wide range of estimates exists, with high and low targets of $25.42 and $24.92, respectively, highlighting the market's uncertainty.
Xeris Biopharma Holdings Inc Stock (XERS) Year by Year Forecast
Xeris Biopharma Holdings Inc Stock (XERS) Price Forecast for 2024
Our forecast for XERS stock price in 2024 now indicates an average price target of $1.6617 with a high forecast of $3.26 and a low forecast of $0.0634. The average prediction reflects an decrease of -42.70% from the last recorded price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.8522 | $1.3022 | $1.3945 | -70.61% |
Xeris Biopharma Holdings Inc Stock (XERS) Price Forecast for 2025
Xeris Biopharma Holdings Inc Stock (XERS) is expected to reach an average price of $4.3057 in 2025, with a high prediction of $7.1204 and a low estimate of $1.4911. This indicates an +48.47% rise from the last recorded price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.3365 | $1.4911 | $2.0765 | +15.05% |
| February, 2025 | $2.9819 | $3.653 | $3.0242 | +2.82% |
| March, 2025 | $5.7373 | $3.4507 | $4.7973 | +97.84% |
| April, 2025 | $7.2166 | $6.6062 | $7.0339 | +148.85% |
| May, 2025 | $7.242 | $7.302 | $7.1204 | +149.72% |
| June, 2025 | $5.0424 | $5.7724 | $6.2047 | +73.88% |
| July, 2025 | $3.3867 | $3.8601 | $3.379 | +16.78% |
| August, 2025 | $5.9021 | $5.9133 | $5.8844 | +103.52% |
| September, 2025 | $5.0575 | $5.6175 | $5.4787 | +74.40% |
| October, 2025 | $3.7818 | $4.1029 | $3.9941 | +30.41% |
| November, 2025 | $2.2072 | $2.5372 | $3.0107 | -23.89% |
| December, 2025 | $3.2515 | $2.3949 | $2.4315 | +12.12% |
Xeris Biopharma Holdings Inc Stock (XERS) Price Forecast for 2026
The predicted value for Xeris Biopharma Holdings Inc (XERS) in 2026 is set at an average of $2.6265. Estimates vary from a peak of $4.2699 to a trough of $0.9832, indicating an -9.43% surge from the present price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.3269 | $2.8592 | $3.0969 | +14.72% |
| February, 2026 | $3.0723 | $3.2523 | $3.2458 | +5.94% |
| March, 2026 | $2.2377 | $2.4377 | $2.0112 | -22.84% |
| April, 2026 | $1.472 | $0.9832 | $1.6619 | -49.24% |
| May, 2026 | $2.8874 | $2.3009 | $2.4574 | -0.43% |
| June, 2026 | $2.9728 | $2.754 | $2.7251 | +2.51% |
| July, 2026 | $3.6121 | $3.3394 | $3.3671 | +24.56% |
| August, 2026 | $2.9725 | $3.2125 | $3.5048 | +2.50% |
| September, 2026 | $2.7968 | $2.7891 | $2.5568 | -3.56% |
| October, 2026 | $4.3422 | $3.3607 | $3.533 | +49.73% |
| November, 2026 | $3.7576 | $3.7976 | $4.2699 | +29.57% |
| December, 2026 | $3.9119 | $3.8165 | $3.7831 | +34.89% |
Xeris Biopharma Holdings Inc Stock (XERS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Xeris Biopharma Holdings Inc (XERS) is $3.483, with a high forecast of $4.2073 and a low forecast of $2.7587. This indicates an +20.10% increase from the last price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.4073 | $3.9208 | $4.2073 | +51.98% |
| February, 2027 | $3.8428 | $3.8828 | $4.105 | +32.51% |
| March, 2027 | $3.597 | $3.947 | $3.9093 | +24.04% |
| April, 2027 | $3.6124 | $3.4236 | $3.3124 | +24.57% |
| May, 2027 | $3.5579 | $3.6713 | $3.5902 | +22.69% |
| June, 2027 | $3.2321 | $3.2556 | $3.1321 | +11.45% |
| July, 2027 | $2.8676 | $2.7587 | $2.781 | -1.12% |
| August, 2027 | $2.973 | $2.8964 | $2.8391 | +2.52% |
| September, 2027 | $2.8872 | $3.0218 | $3.1195 | -0.44% |
| October, 2027 | $3.2027 | $2.936 | $3.1127 | +10.44% |
| November, 2027 | $3.1981 | $3.3615 | $3.3742 | +10.28% |
| December, 2027 | $2.8724 | $3.0824 | $3.2646 | -0.95% |
Xeris Biopharma Holdings Inc Stock (XERS) Price Forecast for 2028
In 2028, Xeris Biopharma Holdings Inc (XERS) is projected to reach an average price of $1.7218, with a high projection of $2.9898 and a low estimate of $0.4539. This indicates an -40.63% fall from the last price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.8378 | $2.9512 | $2.9389 | -2.15% |
| February, 2028 | $2.9332 | $2.8766 | $2.8432 | +1.14% |
| March, 2028 | $2.7375 | $2.7375 | $2.9898 | -5.60% |
| April, 2028 | $2.8129 | $2.8063 | $2.7829 | -3.00% |
| May, 2028 | $2.7972 | $2.6406 | $2.7372 | -3.55% |
| June, 2028 | $2.7126 | $2.7826 | $2.686 | -6.46% |
| July, 2028 | $2.668 | $2.6503 | $2.6114 | -8.00% |
| August, 2028 | $2.4423 | $2.3584 | $2.3668 | -15.78% |
| September, 2028 | $1.6377 | $1.8877 | $2.2311 | -43.53% |
| October, 2028 | $1.0031 | $1.2031 | $1.2665 | -65.41% |
| November, 2028 | $0.4274 | $0.6308 | $0.6085 | -85.26% |
| December, 2028 | $0.5028 | $0.4539 | $0.2901 | -82.66% |
Xeris Biopharma Holdings Inc Stock (XERS) Price Forecast for 2029
The 2029 price forecast for Xeris Biopharma Holdings Inc Stock (XERS) is $4.1814 on average, with a high prediction of $8.34 and a low estimate of $0.0227. This represents an +44.18% increase from the previous price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.3571 | $0.4514 | $0.4716 | -87.69% |
| February, 2029 | $0.6925 | $0.3959 | $0.4536 | -76.12% |
| March, 2029 | $0.7179 | $0.4852 | $0.5429 | -75.24% |
| April, 2029 | $1.0133 | $0.9068 | $0.8233 | -65.06% |
| May, 2029 | $0.7526 | $0.6887 | $0.661 | -74.05% |
| June, 2029 | $0.423 | $0.533 | $0.6264 | -85.41% |
| July, 2029 | $0.1616 | $0.1079 | $0.2477 | -94.43% |
| August, 2029 | $0.4273 | $0.0227 | $0.8939 | -85.27% |
| September, 2029 | $1.1019 | $0.4209 | $1.3419 | -62.00% |
| October, 2029 | $0.3476 | $0.3065 | $1.4353 | -88.01% |
| November, 2029 | $0.1122 | $0.0622 | $0.5699 | -96.13% |
| December, 2029 | $8.91 | $0.0933 | $8.34 | +207.24% |
Xeris Biopharma Holdings Inc Stock (XERS) Price Forecast for 2030
Xeris Biopharma Holdings Inc Stock (XERS) is expected to reach an average price of $12.58 in 2030, with a high forecast of $16.17 and a low forecast of $8.9898. This signifies an +333.75% surge from the last price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.32 | $9.6677 | $11.11 | +290.29% |
| February, 2030 | $8.6394 | $9.3194 | $9.7363 | +197.91% |
| March, 2030 | $9.8702 | $8.9898 | $8.4702 | +240.35% |
| April, 2030 | $8.7411 | $9.6333 | $9.0979 | +201.42% |
| May, 2030 | $10.04 | $9.9788 | $9.9796 | +246.37% |
| June, 2030 | $11.66 | $11.55 | $10.64 | +302.08% |
| July, 2030 | $11.30 | $11.39 | $11.40 | +289.62% |
| August, 2030 | $11.64 | $10.93 | $10.67 | +301.37% |
| September, 2030 | $13.07 | $11.63 | $12.05 | +350.71% |
| October, 2030 | $14.60 | $12.77 | $13.08 | +403.42% |
| November, 2030 | $16.12 | $14.65 | $15.79 | +455.86% |
| December, 2030 | $16.40 | $16.29 | $16.17 | +465.37% |
4.27%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):